Command Palette

Search for a command to run...

Clinical Trials · NCT00349258

The Use of GnRH Agonist Trigger in the Prevention of OHSS

CompletedPhase 4Gonadorelin (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
University of Connecticut
Enrollment
66
Start date
Aug 2004
Locations
1 site, United States
Primary endpoint
OHSS occurrence assessed one week after oocyte retrieval
View Gonadorelin compound reference